Efficacy and safety of apatinib in the treatment of osteosarcoma: a single-arm meta-analysis among Chinese patients

BACKGROUND: Osteosarcoma is a relatively rare malignant tumor with a high incidence in young people. The development of tyrosine kinase inhibitors has brought the treatment of osteosarcoma into a new stage. Apatinib, a tyrosine kinase inhibitor specifically targeting VEGFR2, has been increasingly re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Hui, Chen, Xuyu, Tan, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063308/
https://www.ncbi.nlm.nih.gov/pubmed/33892656
http://dx.doi.org/10.1186/s12885-021-08154-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063308/
https://www.ncbi.nlm.nih.gov/pubmed/33892656
http://dx.doi.org/10.1186/s12885-021-08154-3

Ejemplares similares